6533b7defe1ef96bd1276977

RESEARCH PRODUCT

Relationship Between Cognitive-Behavioral Impairment and Clinical and Functional Parameters in ALS and Reliability of the Edinburgh Cognitive and Behavioural ALS Screen to Assess ALS: Preliminary Findings

José Luis DíazJesús Marcial Conill SanchoEmilio ServeraEduardo J AguilarHelena Mondragón

subject

Malemedicine.medical_specialtyScreening testCognitive NeuroscienceNeuropsychological TestsAudiology050105 experimental psychology03 medical and health sciences0302 clinical medicinemedicineHumansCognitive Dysfunction0501 psychology and cognitive sciencesTest selectionAmyotrophic lateral sclerosisSet (psychology)Reliability (statistics)business.industryAmyotrophic Lateral Sclerosis05 social sciencesNeuropsychologyCognitionGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthNeuropsychology and Physiological PsychologyFemaleCognition Disordersbusiness030217 neurology & neurosurgery

description

Background Although it is widely recognized that a high percentage of individuals with amyotrophic lateral sclerosis (ALS) have cognitive and behavioral impairment, the associated clinical and functional parameters remain unknown. ALS is typically assessed via screening tests, such as the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Objective To investigate the relationship between cognitive-behavioral impairment and other clinical and functional parameters and to compare the assessment results from a set of standardized neuropsychological tests with those from the ECAS. Methods Forty individuals with ALS participated in the study. We assessed attention, memory and learning ability, and executive function using a set of standardized neuropsychological tests and the ECAS. Sociodemographic variables, time since onset of symptoms, time since diagnosis, and functional respiratory values were recorded. Results No relationship was found between time since onset of symptoms and time since definitive diagnosis and either attention (P=0.206, 0.314, respectively), memory and learning ability (P=0.618, 0.692), or executive function (P=0.844, 0.583). The set of standardized neuropsychological tests identified an impairment in executive function in 29% of the participants, whereas the ECAS identified it in 89%. Conclusions We found no relationship between cognitive-behavioral impairment and time since onset of symptoms nor time since ALS diagnosis. Because the ECAS does not correctly reflect the executive function of individuals with ALS, function-specific neuropsychological tests are preferred. Test selection must take into account individuals' physical characteristics and their consequent ability to respond gesturally or orally.

https://doi.org/10.1097/wnn.0000000000000199